Why a Dendritic Approach to Nanomedicines?Wednesday, 26 March 2014 at 11:15 Add to Calendar ▼2014-03-26 11:15:002014-03-26 12:15:00Europe/LondonWhy a Dendritic Approach to Nanomedicines?Nanomedicine in Edinburgh, UKEdinburgh, UKSELECTBIOenquiries@selectbiosciences.com The small size of the dendritic objects and the dendronized nanoparticles is mandatory as it allows envisaging a crossing of the capillary barrier, a urinary elimination and a favourable biodistribution: in vivo studies performed with dendritic 111In-radiopharmaceuticals on melanoma cancer and for the characterization of the sentinel lymph node, but also pre-clinical studies performed with dendronized iron oxides of various sizes and shapes will be discussed. |